Aclarion (ACON) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.85, -5.27% vs the prior close of $1.95.
- Volume 11.30K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ACON slides 5.3% to $1.85, a 52-week low. Closed at $1.85, -5.27% vs the prior close of $1.95. Day range $1.85–$1.94, opened at $1.94.
ACON daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ACON slides 5.3% to $1.85, a 52-week low
- Closed at $1.85, -5.27% vs the prior close of $1.95. Day range $1.85–$1.94, opened at $1.94.
- Volume was 11.30K shares, 0.2x its 50-day average of 53.33K — lighter than usual.
- Price is -24.0% vs its 50-day average ($2.43) and -38.6% vs its 200-day average ($3.02).
- 52-week range $1.85–$9.36; today's close sits at 0% of that range, 80.2% below the 52-week high.
Oct 15, 2026 — ACON rises 0.7% to $1.95
- Closed at $1.95, +0.67% vs the prior close of $1.94. Day range $1.90–$2.02, opened at $1.90.
- Volume was 7.20K shares, 0.1x its 50-day average of 53.65K — lighter than usual.
- Price is -20.1% vs its 50-day average ($2.44) and -35.5% vs its 200-day average ($3.03).
- 52-week range $1.89–$9.38; today's close sits at 1% of that range, 79.2% below the 52-week high.
Oct 14, 2026 — ACON slides 9.3% to $1.94, a 52-week low, 3 down days in a row
- Closed at $1.94, -9.35% vs the prior close of $2.14. Day range $1.89–$2.14, opened at $2.14.
- Volume was 70.90K shares, 1.3x its 50-day average of 53.00K.
- Price is -20.9% vs its 50-day average ($2.45) and -36.3% vs its 200-day average ($3.04).
- 52-week range $1.89–$9.77; today's close sits at 1% of that range, 80.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ACON slides 4.7% to $2.14, a 1-month low
- Closed at $2.14, -4.68% vs the prior close of $2.24. Day range $2.09–$2.25, opened at $2.25.
- Volume was 21.40K shares, 0.4x its 50-day average of 53.73K — lighter than usual.
- Price is -13.0% vs its 50-day average ($2.46) and -30.1% vs its 200-day average ($3.06).
- 52-week range $1.95–$12.03; today's close sits at 2% of that range, 82.2% below the 52-week high.
Oct 12, 2026 — ACON slides 4.1% to $2.24, a 1-month low
- Closed at $2.24, -4.06% vs the prior close of $2.34. Day range $2.22–$2.35, opened at $2.34.
- Volume was 27.00K shares, 0.5x its 50-day average of 54.20K — lighter than usual.
- Price is -8.9% vs its 50-day average ($2.47) and -27.1% vs its 200-day average ($3.08).
- 52-week range $1.95–$12.03; today's close sits at 3% of that range, 81.3% below the 52-week high.
Oct 9, 2026 — ACON rises 1.3% to $2.34
- Closed at $2.34, +1.30% vs the prior close of $2.31. Day range $2.32–$2.37, opened at $2.32.
- Volume was 7.20K shares, 0.1x its 50-day average of 55.62K — lighter than usual.
- Price is -5.1% vs its 50-day average ($2.47) and -24.5% vs its 200-day average ($3.10).
- 52-week range $1.95–$12.03; today's close sits at 4% of that range, 80.5% below the 52-week high.
Oct 8, 2026 — ACON dips 1.7% to $2.31
- Closed at $2.31, -1.70% vs the prior close of $2.35. Day range $2.30–$2.41, opened at $2.36.
- Volume was 31.60K shares, 0.6x its 50-day average of 56.58K — lighter than usual.
- Price is -6.1% vs its 50-day average ($2.46) and -25.9% vs its 200-day average ($3.12).
- 52-week range $1.95–$12.03; today's close sits at 4% of that range, 80.8% below the 52-week high.
Oct 7, 2026 — ACON rises 2.6% to $2.35
- Closed at $2.35, +2.62% vs the prior close of $2.29. Day range $2.32–$2.39, opened at $2.32.
- Volume was 10.40K shares, 0.2x its 50-day average of 57.50K — lighter than usual.
- Price is -4.2% vs its 50-day average ($2.45) and -25.1% vs its 200-day average ($3.14).
- 52-week range $1.95–$12.03; today's close sits at 4% of that range, 80.5% below the 52-week high.
Oct 6, 2026 — ACON dips 2.1% to $2.29, a 1-month low, 3 down days in a row
- Closed at $2.29, -2.14% vs the prior close of $2.34. Day range $2.28–$2.36, opened at $2.35.
- Volume was 30.90K shares, 0.5x its 50-day average of 58.03K — lighter than usual.
- Price is -6.5% vs its 50-day average ($2.45) and -27.5% vs its 200-day average ($3.16).
- 52-week range $1.95–$12.03; today's close sits at 3% of that range, 81.0% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — ACON dips 1.7% to $2.34
- Closed at $2.34, -1.68% vs the prior close of $2.38. Day range $2.33–$2.39, opened at $2.35.
- Volume was 33.20K shares, 0.6x its 50-day average of 57.80K — lighter than usual.
- Price is -4.4% vs its 50-day average ($2.45) and -26.3% vs its 200-day average ($3.17).
- 52-week range $1.95–$12.03; today's close sits at 4% of that range, 80.5% below the 52-week high.
Oct 2, 2026 — ACON dips 2.5% to $2.38
- Closed at $2.38, -2.46% vs the prior close of $2.44. Day range $2.35–$2.47, opened at $2.47.
- Volume was 15.70K shares, 0.3x its 50-day average of 58.33K — lighter than usual.
- Price is -2.8% vs its 50-day average ($2.45) and -25.5% vs its 200-day average ($3.19).
- 52-week range $1.95–$12.03; today's close sits at 4% of that range, 80.2% below the 52-week high.
ACON latest news & SEC filings
Every SEC filing by or about ACON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $25.21K (prior year $19.32K) (+30.5% vs Jun 30, 2025)
- Net income: -$2.75M (prior year -$1.60M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.12 (prior year -$2.75) (loss narrowed vs Jun 30, 2025)
Jul 9, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade ACON
- Last results release: Feb 21, 2024 (8-K Item 2.02). Previous ones: Aug 25, 2023, May 23, 2023, May 16, 2023. Based on that rhythm, the next report is likely around May 22, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.99% (largest 11.8%). That is a volatile stock.
- Liquidity: about 44.57K shares (≈$82.45K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.85 vs a range of $1.85–$9.36 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:27 on Mar 28, 2025, 1:335 on Jan 30, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Amanda M Williams bought 5,857 shares on Aug 17, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Jun 4, 2026; 10-Q May 13, 2026.
- Share count: 2.88M shares outstanding (Aug 4, 2026), +394.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
ACON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.94 | 1.94 | 1.85 | 1.85 | 11.30K |
| Oct 15, 2026 | 1.90 | 2.02 | 1.90 | 1.95 | 7.20K |
| Oct 14, 2026 | 2.14 | 2.14 | 1.89 | 1.94 | 70.90K |
| Oct 13, 2026 | 2.25 | 2.25 | 2.09 | 2.14 | 21.40K |
| Oct 12, 2026 | 2.34 | 2.35 | 2.22 | 2.24 | 27.00K |
| Oct 9, 2026 | 2.32 | 2.37 | 2.32 | 2.34 | 7.20K |
| Oct 8, 2026 | 2.36 | 2.41 | 2.30 | 2.31 | 31.60K |
| Oct 7, 2026 | 2.32 | 2.39 | 2.32 | 2.35 | 10.40K |
| Oct 6, 2026 | 2.35 | 2.36 | 2.28 | 2.29 | 30.90K |
| Oct 5, 2026 | 2.35 | 2.39 | 2.33 | 2.34 | 33.20K |
| Oct 2, 2026 | 2.47 | 2.47 | 2.35 | 2.38 | 15.70K |
| Oct 1, 2026 | 2.45 | 2.50 | 2.43 | 2.44 | 7.10K |
| Sep 30, 2026 | 2.44 | 2.46 | 2.40 | 2.41 | 18.70K |
| Sep 29, 2026 | 2.48 | 2.60 | 2.32 | 2.38 | 79.60K |
| Sep 28, 2026 | 2.64 | 2.72 | 2.39 | 2.44 | 75.20K |
| Sep 25, 2026 | 2.63 | 2.71 | 2.58 | 2.59 | 29.90K |
| Sep 24, 2026 | 2.61 | 2.68 | 2.55 | 2.63 | 61.40K |
| Sep 23, 2026 | 2.57 | 2.96 | 2.56 | 2.94 | 307.90K |
| Sep 22, 2026 | 2.52 | 2.64 | 2.48 | 2.63 | 33.90K |
| Sep 21, 2026 | 2.47 | 2.52 | 2.46 | 2.46 | 10.90K |
About Aclarion
Aclarion (ACON) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in BROOMFIELD, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1635077.
ACON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ryan Bond | Director | Aug 17, 2026 |
| Scott Breidbart | Director | Jun 12, 2026 |
| Stephen Deitsch | Director | Jun 12, 2026 |
| David K Neal | Director | Aug 17, 2026 |
| Brent Ness | Chief Executive Officer | Aug 17, 2026 |
| Amanda Mae Sequira | Director | Jun 12, 2026 |
| Jeffrey John Thramann | Executive Chairman | Jun 12, 2026 |
| William Wesemann | Director | Aug 17, 2026 |
| Amanda M Williams | Director | Aug 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gregory A Gould | CFO | Aug 18, 2026 |
| Brent Ness | Chief Executive Officer | Aug 17, 2026 |
| Jeffrey John Thramann | Executive Chairman | Jun 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | Ryan Bond | Buy | 21,122 | $2.37 |
| Aug 13, 2026 | Ryan Bond | Buy | 21,122 | $2.37 |
| Aug 13, 2026 | Ryan Bond | Buy | 21,122 | $2.37 |
ACON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $75.73K | $-7.23M | -13.61 | $-7.16M |
| Dec 31, 2024 | $45.72K | $-6.99M | -7,478.90 | $-5.27M |
| Dec 31, 2023 | $75.40K | $-4.91M | -79,782.00 | $-3.65M |
| Dec 31, 2022 | $60.44K | $-7.07M | -19.61 | $-4.95M |
| Dec 31, 2021 | $60.29K | $-4.95M | -6.58 | $-2.40M |
Latest balance sheet: total assets $18.04M, total liabilities $1.04M, cash $16.29M (as of Jun 30, 2026).
ACON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Feb 21, 2024 | 8-K Item 2.02 (results) | — |
| Aug 25, 2023 | 8-K Item 2.02 (results) | — |
| May 23, 2023 | 8-K Item 2.02 (results) | — |
| May 16, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ACON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.